Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax ... Moderna's first bivalent shot mRNA-1273. ...

Moderna has reported preliminary clinical results with a bivalent version of its COVID ... lasting protection compared to the original SpikeVax shot against all SARS-CoV-2 variants, including ...

On Thursday, the federal health regulator announced it has given the green light to Moderna's Omicron-targeting bivalent COVID-19 vaccine, for those ages 18 years and older. The "Spikevax Bivalent ...

adding that the bivalent Moderna Spikevax booster is safe and effective with the same mild adverse reactions that resolved quickly, Xinhua news agency reported. Clinical trial results showed that ...